Genius Sports Limited (GENI) concluded trading on Wednesday at a closing price of $10.22, with 3.99 million shares of worth about $40.77 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.03% during that period and on April 16, 2025 the price saw a gain of about 0.59%. Currently the company’s common shares owned by public are about 239.82M shares, out of which, 216.07M shares are available for trading.
Stock saw a price change of 6.68% in past 5 days and over the past one month there was a price change of 9.30%. Year-to-date (YTD), GENI shares are showing a performance of 18.15% which increased to 98.45% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.91 but also hit the highest price of $11.16 during that period. The average intraday trading volume for Genius Sports Limited shares is 3.29 million. The stock is currently trading 2.58% above its 20-day simple moving average (SMA20), while that difference is up 7.25% for SMA50 and it goes to 23.86% higher than SMA200.
Genius Sports Limited (NYSE: GENI) currently have 239.82M outstanding shares and institutions hold larger chunk of about 76.50% of that.
The stock has a current market capitalization of $2.64B and its 3Y-monthly beta is at 1.95. It has posted earnings per share of -$0.28 in the same period. It has Quick Ratio of 1.42 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GENI, volatility over the week remained 4.69% while standing at 6.69% over the month.
Stock’s fiscal year EPS is expected to rise by 116.77% while it is estimated to increase by 290.97% in next year.
Coverage by Guggenheim stated Genius Sports Limited (GENI) stock as a Buy in their note to investors on March 18, 2025, suggesting a price target of $12 for the stock. On June 13, 2024, Citigroup Resumed their recommendations, while on April 16, 2024, Goldman Initiated their ratings for the stock with a price target of $7.50. Stock get a Buy rating from B. Riley Securities on April 05, 2024.
